Li Weiya, Yin Han, Liu Quanjun, Chen Yilin, Liang Yanting, Zhou Haofeng, Ma Huan, Geng Qingshan
Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
School of Medicine, South China University of Technology, Guangzhou, China.
Front Psychiatry. 2022 Jun 16;13:815196. doi: 10.3389/fpsyt.2022.815196. eCollection 2022.
Depression is ubiquitous in patients with coronary artery disease (CAD). The relationship between depression and hemoglobin A1c (HbA1c) is controversial. The combined effect of high HbA1c and depression on prognosis is unclear, especially in non-diabetic CAD patients. We sought to explore these associations.
558 CAD patients were included in this prospective study. Patients were grouped by HbA1c levels and the status of clinical depression. The average follow-up period was about 2.2 years, and Cox proportional hazards models were used to compare the differences of prognosis in all the groups.
Clinical depression had no associations with HbA1c in all CAD patients (P for Pearson correlation = 0.74). In the all four groups, compared to group 1 (patients without clinical depression and low HbA1c), group 3 (without clinical depression and high HbA1c) had a higher risk of MACE (adjusted hazard ratio [aHR], 1.97; 95% confidence interval [CI], 1.2-3.25) and composite events (aHR, 1.67; 95% CI, 1.09-2.053). Group 4 (patients with clinical depression and high HbA1c) had higher HRs for MACE (aHR, 2.9; 95%CI, 1.32-6.38) and composite events (aHR, 2.12; 95% CI, 1.06-4.25). In CAD patients without diabetes, patients with clinical depression and high HbA1c had a higher risk of MACE (HR, 2.71; 95% CI, 1.02-7.19), non-cardiac readmission (HR,3.48; 95% CI, 1.26-9.57) and composite events (HR,2.44; 95% CI, 1.08-5.53) than those with no clinical depression and low HbA1c. In patients with comorbidities of depression and diabetes, patients with depression and high HbA1c more likely to experienced non-cardiac readmissions (HR, 4.49; 95% CI, 1.31-15.38) than patients with no depression and low HbA1c only. In all the above analysis, p-values for interaction between clinical depression and HbA1c were not statistically significant.
The presence of both depression and high HbA1c lead to a worse prognosis in CAD patients than one risk factor alone, no matter with or without the comorbidity of diabetes in these CAD patients. For patients with CAD and depression, lower HbA1c may be required.
抑郁症在冠状动脉疾病(CAD)患者中普遍存在。抑郁症与糖化血红蛋白(HbA1c)之间的关系存在争议。高HbA1c和抑郁症对预后的综合影响尚不清楚,尤其是在非糖尿病CAD患者中。我们试图探讨这些关联。
558例CAD患者纳入本前瞻性研究。患者按HbA1c水平和临床抑郁状态分组。平均随访期约2.2年,采用Cox比例风险模型比较所有组的预后差异。
在所有CAD患者中,临床抑郁症与HbA1c无关联(Pearson相关系数P = 0.74)。在所有四组中,与第1组(无临床抑郁症且HbA1c低的患者)相比,第3组(无临床抑郁症且HbA1c高)发生主要不良心血管事件(MACE)的风险更高(调整后风险比[aHR],1.97;95%置信区间[CI],1.2 - 3.25)和复合事件风险更高(aHR,1.67;95%CI,1.09 - 2.053)。第4组(有临床抑郁症且HbA1c高的患者)发生MACE的风险更高(aHR,2.9;95%CI,1.32 - 6.38)和复合事件风险更高(aHR,2.12;95%CI,1.06 - 4.25)。在无糖尿病的CAD患者中,有临床抑郁症且HbA1c高的患者发生MACE的风险更高(HR,2.71;95%CI,1.02 - 7.19)、非心脏再入院风险更高(HR,3.48;95%CI,1.26 - 9.57)和复合事件风险更高(HR,2.44;95%CI,1.08 - 5.53),高于无临床抑郁症且HbA1c低的患者。在合并抑郁症和糖尿病的患者中,有抑郁症且HbA1c高的患者比仅有无抑郁症且HbA1c低的患者更易发生非心脏再入院(HR,4.49;95%CI,1.31 - 15.38)。在上述所有分析中,临床抑郁症与HbA1c之间的交互作用p值无统计学意义。
抑郁症和高HbA1c同时存在会使CAD患者的预后比单一危险因素更差,无论这些CAD患者是否合并糖尿病。对于患有CAD和抑郁症的患者,可能需要降低HbA1c水平。